ScreenerHero

VLA Valneva SE

EPA · FR · Healthcare · Biotechnology · valneva.com
2.565EUR+0.47%Mkt Cap: 528.74M $P/E: —

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese ence…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap528.74M USD
Enterprise Value618.15M USD
Revenue (TTM)155.37M USD
Gross Profit73.39M USD
Net Income (TTM)-125.21M USD
Revenue/Share0.80 EUR
Last Price2.565 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees620
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0004056851
Valuation
P/E (Trailing)—
P/E (Forward)16.44
PEG-13.06
EV/EBITDA-5.76
EV/Revenue3.98
P/S3.36
P/B5.91
EPS (TTM)-0.90
EPS (Forward)0.15
52W Range
2.03317% of range5.150
52W High5.150 EUR
52W Low2.033 EUR
Profitability
Gross Margin38.66%
Oper. Margin-74.92%
EBITDA Margin-69.07%
Profit Margin-65.95%
ROE-108.50%
ROA-28.88%
Growth
Revenue Growth-27.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-57.49M USD
CapEx (TTM)4.87M USD
FCF Margin-29.73%
FCF Yield-8.74%
Net Debt96.42M USD
Net Debt/EBITDA-0.90
Balance Sheet
Debt/Equity1.95
Current Ratio2.16
Quick Ratio1.33
Book Value/Sh0.43 EUR
Cash/Share0.64 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.193 EUR
Upside (mean)+141.4%
Target Range2.150 EUR – 12.00 EUR
2.150+141.4% to mean12.00
# Analysts7
Ownership
Shares Out.189.65M
Float171.36M
Insiders10.72%
Institutions23.48%
Technical
SMA 502.682 (-4.3%)
SMA 2003.070 (-16.5%)
Beta1.37
S&P 52W Chg14.58%
Avg Vol (30d)590.31K
Avg Vol (10d)327.46K
Technical Indicators
RSI (14)39.2
MACD-0.0496
MACD Signal-0.0124
MACD Hist.-0.0372
BB Upper3.002 EUR
BB Middle2.756 EUR
BB Lower2.510 EUR
BB Width17.83%
ATR (14)0.1115 EUR
Vol Ratio (20d)1.57x